Compare MRNA & TSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | TSN |
|---|---|---|
| Founded | 2010 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 23.4B |
| IPO Year | 2018 | 1994 |
| Metric | MRNA | TSN |
|---|---|---|
| Price | $72.47 | $58.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 10 |
| Target Price | $34.27 | ★ $66.90 |
| AVG Volume (30 Days) | ★ 7.6M | 3.6M |
| Earning Date | 05-01-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $19,263,000,000.00 | ★ $54,441,000,000.00 |
| Revenue This Year | $9.36 | $5.74 |
| Revenue Next Year | $15.43 | $1.14 |
| P/E Ratio | ★ N/A | $58.94 |
| Revenue Growth | ★ 4.29 | 2.12 |
| 52 Week Low | $22.28 | $50.56 |
| 52 Week High | $73.28 | $69.48 |
| Indicator | MRNA | TSN |
|---|---|---|
| Relative Strength Index (RSI) | 74.31 | 46.74 |
| Support Level | $45.69 | $57.70 |
| Resistance Level | N/A | $59.04 |
| Average True Range (ATR) | 5.14 | 1.23 |
| MACD | 1.66 | 0.46 |
| Stochastic Oscillator | 92.36 | 80.80 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, composing about 40% and 30% of sales, respectively. Prepared foods constituted 18% of fiscal 2025 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.